Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene
Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there i...
Saved in:
Published in | The international journal of neuropsychopharmacology Vol. 18; no. 2; p. pyu032 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.Methods:The purpose of this study was to examine NaB’s putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).Results:The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.Conclusions:Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1. |
---|---|
AbstractList | Background: Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation. Methods: The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line). Results: The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression. Conclusions: Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1. Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.BACKGROUNDEpigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation.The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).METHODSThe purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line).The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.RESULTSThe FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression.Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.CONCLUSIONSOur data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1. Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation. The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line). The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression. Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1. |
Author | Lavebratt, Catharina Mathé, Aleksander A. Wei, Ya Bin Melas, Philippe A. Wegener, Gregers |
Author_xml | – sequence: 1 givenname: Ya Bin surname: Wei fullname: Wei, Ya Bin email: yabin.wei@ki.se organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé) – sequence: 2 givenname: Philippe A. surname: Melas fullname: Melas, Philippe A. organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé) – sequence: 3 givenname: Gregers surname: Wegener fullname: Wegener, Gregers organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé) – sequence: 4 givenname: Aleksander A. surname: Mathé fullname: Mathé, Aleksander A. organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé) – sequence: 5 givenname: Catharina surname: Lavebratt fullname: Lavebratt, Catharina organization: Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden (Drs Wei, Melas, and Lavebratt); Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark (Dr Wegener); Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa (Dr Wegener); and Department of Clinical Neuroscience, Section for Psychiatry, Karolinska Institutet, Stockholm, Sweden (Dr Mathé) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25618518$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:131079937$$DView record from Swedish Publication Index |
BookMark | eNqNkk1v1DAQhiNURD_gxB1ZQkJIKNSTxIlzqbStlrbSShxYzpaTTFhvEzvYTkv-AT8bb7NFtEKIk8fzPvNqxp7j6EAbjVH0GuhHoGV6qrZ6OB2mkabJs-gIsryMGQAc3McQQ8aKw-jYuS2lScbS_EV0mLAcOAN-FP1caK8aHCw6J7WPV-oGybJtsfbEtOSLadTYk_PRT1Z6JMqRhXOmVuHSkDvlN0Rqcq1ri9IFWZP1cg0h1-xiFl9NjTU_ph79ZuqkV0aTFd5i53ay3yA5b3RLLlHjy-h5KzuHr_bnSfT103J9cRWvPl9eXyxWcc04-BhYzlLAXJYZFm1W1SVvZClLyjk20BZZJfMwfMIZR-QMZVoWVcppARSqJGvTkyiefd0dDmMlBqt6aSdhpBL71E2IUDDIIU0CfzbzQemxqVF7K7tHZY8VrTbim7kVWZpzXkIweL83sOb7iM6LXrkau05qNKMTUOSsLFhJ_wPNWZJRSjkN6Nsn6NaMVoeXEykUFLLQOgvUmz-b_931w_8HAGagtsY5i62olb__pzCL6gRQsdsxsdsxMe9YqPnwpObB9u_0u5k24_BP8Bc9r-JR |
CitedBy_id | crossref_primary_10_3389_fcimb_2020_567268 crossref_primary_10_3389_fnins_2023_1151478 crossref_primary_10_1093_cercor_bhx095 crossref_primary_10_3389_fpsyt_2018_00454 crossref_primary_10_1016_j_neulet_2016_02_009 crossref_primary_10_1093_ijnp_pyw069 crossref_primary_10_1016_j_jad_2019_02_009 crossref_primary_10_3390_ijms22062973 crossref_primary_10_3233_JAD_215290 crossref_primary_10_3390_microorganisms12102006 crossref_primary_10_1097_MOG_0000000000000244 crossref_primary_10_3390_ijms26031082 crossref_primary_10_3389_fgene_2023_1158954 crossref_primary_10_3389_fphar_2021_712531 crossref_primary_10_1016_j_neuropharm_2021_108782 crossref_primary_10_1016_j_ijdevneu_2017_03_007 crossref_primary_10_3390_molecules28073213 crossref_primary_10_2174_1570159X20666220201084536 crossref_primary_10_1016_j_gtc_2019_04_006 crossref_primary_10_1021_acsomega_3c05846 crossref_primary_10_33619_2414_2948_61_15 crossref_primary_10_1096_fj_201601340RR crossref_primary_10_2217_epi_2017_0077 crossref_primary_10_3389_fnbeh_2017_00041 crossref_primary_10_1007_s10571_021_01108_0 crossref_primary_10_3390_ijms24076617 crossref_primary_10_3389_fnins_2019_01361 crossref_primary_10_1038_s41380_023_02099_8 crossref_primary_10_1016_j_biocel_2015_11_002 crossref_primary_10_1016_j_pnpbp_2023_110861 crossref_primary_10_1038_s41598_024_80228_1 crossref_primary_10_1016_j_jad_2022_08_012 crossref_primary_10_1016_j_micres_2023_127440 crossref_primary_10_3390_biomedicines9070704 crossref_primary_10_3389_fnut_2021_750333 crossref_primary_10_3389_fpsyt_2021_641491 crossref_primary_10_1139_gen_2020_0136 crossref_primary_10_1016_j_ecoenv_2021_112108 crossref_primary_10_3390_microorganisms11051334 crossref_primary_10_4235_agmr_19_0014 crossref_primary_10_1002_prp2_70058 crossref_primary_10_1080_10408398_2022_2137776 crossref_primary_10_1126_scisignal_aac7695 crossref_primary_10_3389_fnins_2023_1134080 crossref_primary_10_1016_j_jbiotec_2016_11_020 crossref_primary_10_5005_jp_journals_10006_2411 crossref_primary_10_3390_nu14193946 crossref_primary_10_1016_j_neuro_2017_06_007 crossref_primary_10_1016_j_biopha_2024_116420 crossref_primary_10_3346_jkms_2023_38_e120 crossref_primary_10_3389_fnut_2022_867150 crossref_primary_10_3390_ijms24043543 crossref_primary_10_1016_j_biopha_2022_113870 crossref_primary_10_1038_s41430_023_01270_2 crossref_primary_10_7717_peerj_10125 crossref_primary_10_1007_s00213_018_4947_z crossref_primary_10_3389_fpsyt_2019_00808 crossref_primary_10_3389_fnins_2022_1029495 crossref_primary_10_1016_j_ygeno_2024_110959 crossref_primary_10_1007_s12035_023_03697_x crossref_primary_10_1186_s13073_019_0621_2 crossref_primary_10_3389_fmicb_2024_1456793 crossref_primary_10_1186_s13024_022_00548_6 crossref_primary_10_1080_10408398_2022_2051164 crossref_primary_10_3389_fnins_2018_00155 crossref_primary_10_3390_nutraceuticals2020007 crossref_primary_10_1016_j_jpsychires_2020_07_018 crossref_primary_10_1016_j_pharmthera_2022_108279 crossref_primary_10_1111_febs_17200 crossref_primary_10_3390_foods14050870 crossref_primary_10_3389_fphys_2024_1338544 crossref_primary_10_3390_ijms25179489 crossref_primary_10_1038_s41467_021_23281_y crossref_primary_10_1111_apm_13257 crossref_primary_10_1136_gpsych_2023_101374 crossref_primary_10_3389_fendo_2020_00025 crossref_primary_10_1016_j_envres_2024_118441 crossref_primary_10_1002_advs_201900752 crossref_primary_10_1016_j_psychres_2021_113987 crossref_primary_10_3389_fimmu_2018_01832 crossref_primary_10_1038_srep37411 crossref_primary_10_1016_j_isci_2023_106627 crossref_primary_10_1007_s40263_016_0370_3 crossref_primary_10_1177_0706743719874168 crossref_primary_10_3390_nu14142982 crossref_primary_10_1016_j_brainres_2024_149125 crossref_primary_10_1016_j_jad_2022_12_035 crossref_primary_10_1002_ddr_21340 crossref_primary_10_1007_s12035_022_02917_0 crossref_primary_10_1186_s12991_023_00469_8 |
Cites_doi | 10.1017/S1461145711000940 10.1001/archpsyc.1994.03950010008002 10.1371/journal.pone.0014524 10.1016/j.biopsych.2006.06.036 10.1126/science.1169786 10.1038/sj.mp.4001637 10.1038/tp.2013.31 10.1016/S0021-9258(17)35855-6 10.1093/carcin/bgl167 10.1002/jnr.21139 10.1016/j.cell.2013.12.020 10.1523/JNEUROSCI.1786-08.2008 10.2174/138161212803523590 10.1038/mp.2010.131 10.1073/pnas.1216100110 10.1016/j.bbr.2012.01.050 10.1016/j.janxdis.2008.03.013 10.1038/nrn2132 10.1038/mp.2012.10 10.1016/0092-8674(78)90306-9 10.1073/pnas.191352298 10.5498/wjp.v2.i3.49 10.1074/jbc.M303740200 10.1126/science.1090842 10.1038/nrm2950 10.1016/S0028-3908(03)00198-9 10.1016/j.neuron.2013.08.032 10.1097/CAD.0b013e32835739dd 10.1016/j.cell.2012.11.022 10.1016/S0006-3223(03)00231-2 10.3109/15622975.2011.585663 10.1016/j.neuron.2010.12.023 10.1016/0092-8674(78)90305-7 10.1124/mol.109.061333 10.1186/gb-2007-8-2-r19 10.1523/JNEUROSCI.5731-07.2008 10.1093/nar/29.17.3603 10.1523/JNEUROSCI.1758-09.2009 10.1177/0269881110393049 10.1101/gad.12.5.599 10.1016/j.neuroscience.2005.12.058 10.1126/science.1170116 10.1523/JNEUROSCI.3136-11.2012 10.1006/excr.1994.1107 10.1016/j.bbr.2008.08.039 10.1101/lm.500907 10.1371/journal.pone.0040262 10.1038/nn1944 10.1038/nn.2207 10.1124/pr.111.005397 10.1016/j.neubiorev.2005.03.015 10.1093/hmg/8.12.2317 10.1016/0167-4781(90)90124-K 10.1371/journal.pone.0058473 10.1016/j.neuron.2005.09.023 10.1038/nn1659 10.1073/pnas.1114863108 10.1111/j.1471-4159.1966.tb09873.x 10.1111/j.1476-5381.2011.01489.x 10.1038/nature12750 10.1038/mp.2011.107 10.1016/j.cell.2011.03.022 10.1111/j.1365-2125.2011.04100.x |
ContentType | Journal Article |
Copyright | The Author 2015. Published by Oxford University Press on behalf of CINP. 2015 The Author 2015. Published by Oxford University Press on behalf of CINP. The Author 2015. Published by Oxford University Press on behalf of CINP. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author 2015. Published by Oxford University Press on behalf of CINP. 2015 – notice: The Author 2015. Published by Oxford University Press on behalf of CINP. – notice: The Author 2015. Published by Oxford University Press on behalf of CINP. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | TOX AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 7TK 5PM ADTPV AOWAS D8T ZZAVC |
DOI | 10.1093/ijnp/pyu032 |
DatabaseName | Oxford Journals Open Access Collection (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Psychology Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford Journals Open Access Collection (WRLC) url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1469-5111 |
EndPage | pyu032 |
ExternalDocumentID | oai_swepub_ki_se_516132 PMC4368891 25618518 10_1093_ijnp_pyu032 10.1093/ijnp/pyu032 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -E. .FH 0E1 0R~ 123 29J 4.4 5VS 74X 74Y 7~V 8R4 8R5 AAFWJ AAMVS AAOGV AAPPN AAPXW AAVAP ABEJV ABGNP ABITZ ABIVO ABKKG ABPTD ABQLI ABVKB ABXVV ACGFS ACIMK ADBBV ADHZD ADRAZ AEMTW AENEX AENZO AFFVI AFULF AFUTZ AHMBA AJ7 ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC AMNDL AOIJS ARABE AVWKF BAWUL BAYMD BCNDV BTTYL C0O CIDKT CS3 DC4 DIK DU5 EBS EJD EMOBN GROUPED_DOAJ H13 HG- HST HYE HZ~ I.6 I~P J36 J38 J3A KQ8 KSI L98 M-V M48 ML0 M~E O9- OAWHX OJQWA OK1 P2P PEELM Q2X RHF ROL ROX RPM RR0 S6- S70 TJX TOX TUQ UU6 WQ3 WXU WYP 7X7 88E 8AO 8FI 8FJ AAYXX ABUWG AFKRA AFPKN AZQEC BENPR CCPQU CITATION DWQXO FYUFA GNUQQ HMCUK M1P M2M PHGZM PHGZT PIMPY PSQYO PSYQQ UKHRP 3V. BPHCQ BVXVI CGR CUY CVF ECM EIF NPM PQQKQ PROAC 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 7TK 5PM 0VX 53G ADTPV AOWAS CAG COF D8T IAO IHR ITC PUEGO ZZAVC |
ID | FETCH-LOGICAL-c581t-156531e6a94e7f4bc98da9a9088ed1f74ba61112858ee85ea397b3807101b24f3 |
IEDL.DBID | 7X7 |
ISSN | 1461-1457 1469-5111 |
IngestDate | Mon Sep 01 03:33:37 EDT 2025 Thu Aug 21 18:30:31 EDT 2025 Fri Jul 11 06:17:42 EDT 2025 Fri Jul 11 12:22:32 EDT 2025 Fri Jul 25 21:46:26 EDT 2025 Wed Feb 19 01:53:31 EST 2025 Tue Jul 01 03:53:12 EDT 2025 Thu Apr 24 22:59:54 EDT 2025 Tue Feb 04 08:58:38 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | DNA methylation TET1 depression epigenetics |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author 2015. Published by Oxford University Press on behalf of CINP. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c581t-156531e6a94e7f4bc98da9a9088ed1f74ba61112858ee85ea397b3807101b24f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3170143235?pq-origsite=%requestingapplication% |
PMID | 25618518 |
PQID | 3170143235 |
PQPubID | 43629 |
PageCount | 10 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_516132 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4368891 proquest_miscellaneous_1765975901 proquest_miscellaneous_1652400080 proquest_journals_3170143235 pubmed_primary_25618518 crossref_citationtrail_10_1093_ijnp_pyu032 crossref_primary_10_1093_ijnp_pyu032 oup_primary_10_1093_ijnp_pyu032 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | The international journal of neuropsychopharmacology |
PublicationTitleAlternate | Int J Neuropsychopharmacol |
PublicationYear | 2015 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Candido (9_4590366) 1978; 14 (43_49653096) 2013; 3 (46_22675046) 2007; 28 Fischer (20_41962185) 2012; 230 Aid (1_23588426) 2007; 85 (31_47715364) 2013; 79 Yamawaki (73_40493093) 2012; 13 (11_49653094) 2012; 17 Benjamin (3_11295946) 2001; 29 Cosgrove (12_9170839) 1990; 1087 Boffa (5_14703568) 1994; 211 Boulle (6_40716573) 2012; 17 (24_35995229) 2010; 77 Martinowich (41_17884507) 2003; 302 (66_34597445) 2009; 324 (23_47494005) 2014; 156 Shin (63_41777870) 2012; 40 Overstreet (50_18888825) 2005; 29 Sealy (61_4590367) 1978; 14 Pandey (51_30723630) 2008; 28 (29_47539373) 2012; 4 (47_45122782) 2013; 110 Dias (16_17758438) 2003; 45 (70_48325913) 2011; 69 (10_37686686) 1999; 8 (27_39012577) 2011; 25 Guo (26_39742981) 2011; 145 (67_48234658) 2013; 8 Angelucci (2_18766994) 2005; 10 Wu (72_37815447) 2010; 11 (15_19562362) 2003; 278 Schroeder (60_28911220) 2007; 62 Biard (4_9982538) 1992; 52 Porsolt (55_4419438) 1977; 229 Dwivedi (17_22090726) 2006; 139 Sales (58_39966655) 2011; 164 West (71_11334367) 2001; 98 Lubin (40_32160629) 2008; 28 Overstreet (49_44870054) 2013; 65 Robinson (57_31365812) 2009; 23 Covington (13_35573231) 2009; 29 Tsankova (68_21847439) 2006; 9 de Haan (14_13689453) 1986; 46 Ressler (56_29320008) 2007; 10 Struhl (64_5925119) 1998; 12 Fava (19_17593975) 2003; 53 Parker (52_13749657) 1986; 261 (62_49653097) 2012; 2 Lu (39_43033534) 2012; 7 Glowinski (21_7173440) 1966; 13 Oldham (48_32196907) 2008; 11 Tsankova (69_28473872) 2007; 8 (42_49653095) 2012; 15 (30_45482195) 2011; 5 Menke (45_42825189) 2012; 18 Eriksson (18_39064815) 2012; 17 (22_46381271) 2013; 18 Kessler (32_14665707) 1994; 51 Hellemans (28_23645204) 2007; 8 (65_49653098) 2013; 7 Gu (25_43367613) 2012; 23 Bredy (7_28300649) 2007; 14 Zhu (74_32035409) 2009; 196 Kumar (36_19495778) 2005; 48 (37_42560642) 2011; 3 (44_45706308) 2012; 151 Peedicayil (53_41090780) 2012; 73 (34_47362447) 2013; 502 (35_34597441) 2009; 324 (38_41040395) 2011; 108 Brenet (8_39107615) 2011; 6 SARKAR (59_40445373) 2011; 31 Ponomarev (54_41601956) 2012; 32 19372391 - Science. 2009 May 15;324(5929):930-5 23319547 - Pharmacol Rev. 2013 Jan;65(1):143-55 23052292 - Sci Transl Med. 2012 Oct 10;4(155):155ps19 17012225 - Carcinogenesis. 2007 Mar;28(3):560-71 16242410 - Neuron. 2005 Oct 20;48(2):303-14 24452011 - Neuropharmacology. 2014 May;80:115-32 22768266 - PLoS One. 2012;7(6):e40262 8143791 - Exp Cell Res. 1994 Apr;211(2):420-3 14593184 - Science. 2003 Oct 31;302(5646):890-3 667927 - Cell. 1978 May;14(1):105-13 21585346 - Br J Pharmacol. 2011 Nov;164(6):1711-21 21267076 - PLoS One. 2011;6(1):e14524 22321459 - Behav Brain Res. 2012 Apr 21;230(1):85-91 23908608 - Front Integr Neurosci. 2013 Jul 29;7:55 15925699 - Neurosci Biobehav Rev. 2005;29(4-5):739-59 21496894 - Cell. 2011 Apr 29;145(3):423-34 23382250 - Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9 16501568 - Nat Neurosci. 2006 Apr;9(4):519-25 24050399 - Neuron. 2013 Sep 18;79(6):1086-93 1382840 - Cancer Res. 1992 Oct 1;52(19):5213-8 23260135 - Cell. 2012 Dec 21;151(7):1417-30 22049069 - Sci Transl Med. 2011 Nov 2;3(107):107ra109 19917878 - Mol Pharmacol. 2010 Feb;77(2):126-35 9499396 - Genes Dev. 1998 Mar 1;12(5):599-606 17453016 - Nat Rev Neurosci. 2007 May;8(5):355-67 667928 - Cell. 1978 May;14(1):115-21 18817816 - Behav Brain Res. 2009 Jan 23;196(2):200-6 16945350 - Biol Psychiatry. 2007 Jul 1;62(1):55-64 2419322 - J Biol Chem. 1986 Feb 25;261(6):2786-90 11572963 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11024-31 23652932 - Transl Psychiatry. 2013;3:e255 25888486 - Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv026. doi: 10.1093/ijnp/pyv026 21868513 - Anticancer Res. 2011 Sep;31(9):2723-32 21894152 - Mol Psychiatry. 2012 Jun;17(6):584-96 22371047 - Mol Psychiatry. 2013 May;18(5):582-94 16500030 - Neuroscience. 2006;139(3):1017-29 23469282 - PLoS One. 2013;8(3):e58473 5950056 - J Neurochem. 1966 Aug;13(8):655-69 17522015 - Learn Mem. 2007 Apr;14(4):268-76 18849986 - Nat Neurosci. 2008 Nov;11(11):1271-82 19372393 - Science. 2009 May 15;324(5929):929-30 10545613 - Hum Mol Genet. 1999 Nov;8(12):2317-23 8279933 - Arch Gen Psychiatry. 1994 Jan;51(1):8-19 22302827 - J Neurosci. 2012 Feb 1;32(5):1884-97 22023150 - Br J Clin Pharmacol. 2012 Feb;73(2):309-10 22863973 - Anticancer Drugs. 2012 Nov;23(10):1054-66 22339643 - Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26 15655562 - Mol Psychiatry. 2005 Apr;10(4):345-52 21242991 - Mol Psychiatry. 2012 Feb;17(2):173-84 21262472 - Neuron. 2011 Jan 27;69(2):359-72 24153300 - Nature. 2013 Oct 24;502(7472):472-9 12706951 - Biol Psychiatry. 2003 Apr 15;53(8):649-59 17291332 - Genome Biol. 2007;8(2):R19 17726478 - Nat Neurosci. 2007 Sep;10(9):1116-24 21682946 - Int J Neuropsychopharmacol. 2012 Jun;15(5):669-79 24175168 - World J Psychiatry. 2012 Jun 22;2(3):49-57 21812623 - World J Biol Psychiatry. 2012 Sep;13(6):458-67 2416432 - Cancer Res. 1986 Feb;46(2):713-6 18571370 - J Anxiety Disord. 2009 Jan;23(1):38-45 21262856 - J Psychopharmacol. 2011 Oct;25(10):1378-87 18385331 - J Neurosci. 2008 Apr 2;28(14):3729-37 22681167 - Curr Pharm Des. 2012;18(36):5879-89 17149751 - J Neurosci Res. 2007 Feb 15;85(3):525-35 22025706 - Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18108-13 12907316 - Neuropharmacology. 2003 Sep;45(4):553-63 11522830 - Nucleic Acids Res. 2001 Sep 1;29(17):3603-10 18923034 - J Neurosci. 2008 Oct 15;28(42):10576-86 1698097 - Biochim Biophys Acta. 1990 Sep 10;1087(1):80-6 20683471 - Nat Rev Mol Cell Biol. 2010 Sep;11(9):607-20 24439381 - Cell. 2014 Jan 16;156(1-2):261-76 19759294 - J Neurosci. 2009 Sep 16;29(37):11451-60 12748177 - J Biol Chem. 2003 Jul 25;278(30):27586-92 22246241 - Int J Oncol. 2012 May;40(5):1533-42 596982 - Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36 22784618 - BMC Syst Biol. 2011;5 Suppl 3:S12 |
References_xml | – volume: 46 start-page: 713 issn: 0008-5472 issue: 2 year: 1986 ident: 14_13689453 publication-title: Cancer Research – volume: 15 start-page: 669 year: 2012 ident: 42_49653095 publication-title: INT J NEUROPSYCHOP doi: 10.1017/S1461145711000940 – volume: 51 start-page: 8 issn: 0003-990X issue: 1 year: 1994 ident: 32_14665707 publication-title: Archives of General Psychiatry doi: 10.1001/archpsyc.1994.03950010008002 – volume: 52 start-page: 5213 issn: 0008-5472 issue: 19 year: 1992 ident: 4_9982538 publication-title: Cancer Research – volume: 6 start-page: e14524 issn: 1932-6203 issue: 1 year: 2011 ident: 8_39107615 doi: 10.1371/journal.pone.0014524 – volume: 62 start-page: 55 issn: 0006-3223 issue: 1 year: 2007 ident: 60_28911220 publication-title: Biological psychiatry doi: 10.1016/j.biopsych.2006.06.036 – volume: 324 start-page: 929 issn: 0036-8075 issue: 5929 year: 2009 ident: 35_34597441 publication-title: Science doi: 10.1126/science.1169786 – volume: 10 start-page: 345 issn: 1359-4184 issue: 4 year: 2005 ident: 2_18766994 publication-title: Molecular psychiatry doi: 10.1038/sj.mp.4001637 – volume: 3 start-page: 255e year: 2013 ident: 43_49653096 publication-title: TRANSL PSYCHIATRY doi: 10.1038/tp.2013.31 – volume: 261 start-page: 2786 issn: 0021-9258 issue: 6 year: 1986 ident: 52_13749657 publication-title: Journal of Biological Chemistry doi: 10.1016/S0021-9258(17)35855-6 – volume: 28 start-page: 560 issn: 0143-3334 issue: 3 year: 2007 ident: 46_22675046 publication-title: Carcinogenesis doi: 10.1093/carcin/bgl167 – volume: 85 start-page: 525 issn: 0360-4012 issue: 3 year: 2007 ident: 1_23588426 publication-title: Journal of neuroscience research doi: 10.1002/jnr.21139 – volume: 156 start-page: 261 issn: 0092-8674 year: 2014 ident: 23_47494005 publication-title: Cell doi: 10.1016/j.cell.2013.12.020 – volume: 28 start-page: 10576 issn: 0270-6474 issue: 42 year: 2008 ident: 40_32160629 publication-title: Journal of Neuroscience doi: 10.1523/JNEUROSCI.1786-08.2008 – volume: 18 start-page: 5879 issn: 1381-6128 year: 2012 ident: 45_42825189 publication-title: Current pharmaceutical design doi: 10.2174/138161212803523590 – volume: 17 start-page: 173 issn: 1359-4184 issue: 2 year: 2012 ident: 18_39064815 publication-title: Molecular psychiatry doi: 10.1038/mp.2010.131 – volume: 110 start-page: 4804 issn: 0027-8424 issue: 12 year: 2013 ident: 47_45122782 publication-title: PNAS doi: 10.1073/pnas.1216100110 – volume: 5 start-page: S12 issn: 1752-0509 year: 2011 ident: 30_45482195 – volume: 230 start-page: 85 issn: 0166-4328 issue: 1 year: 2012 ident: 20_41962185 publication-title: Behavioural brain research doi: 10.1016/j.bbr.2012.01.050 – volume: 23 start-page: 38 issn: 0887-6185 issue: 1 year: 2009 ident: 57_31365812 publication-title: Journal of anxiety disorders doi: 10.1016/j.janxdis.2008.03.013 – volume: 8 start-page: 355 issn: 1471-003X issue: 5 year: 2007 ident: 69_28473872 publication-title: Nature reviews. Neuroscience doi: 10.1038/nrn2132 – volume: 18 start-page: 582 issn: 1359-4184 year: 2013 ident: 22_46381271 publication-title: Molecular psychiatry doi: 10.1038/mp.2012.10 – volume: 229 start-page: 327 issn: 0003-9780 issue: 2 year: 1977 ident: 55_4419438 publication-title: Archives internationales de pharmacodynamie et de th rapie – volume: 14 start-page: 115 issn: 0092-8674 issue: 1 year: 1978 ident: 61_4590367 publication-title: Cell doi: 10.1016/0092-8674(78)90306-9 – volume: 40 start-page: 1533 issn: 1019-6439 issue: 5 year: 2012 ident: 63_41777870 publication-title: International journal of oncology – volume: 31 start-page: 2723 issn: 0250-7005 issue: 9 year: 2011 ident: 59_40445373 publication-title: Anticancer Research – volume: 98 start-page: 11024 issn: 0027-8424 issue: 20 year: 2001 ident: 71_11334367 publication-title: PNAS doi: 10.1073/pnas.191352298 – volume: 2 start-page: 49 year: 2012 ident: 62_49653097 publication-title: WORLD J PSYCHIATRY doi: 10.5498/wjp.v2.i3.49 – volume: 278 start-page: 27586 issn: 0021-9258 issue: 30 year: 2003 ident: 15_19562362 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M303740200 – volume: 302 start-page: 890 issn: 0036-8075 issue: 5646 year: 2003 ident: 41_17884507 publication-title: Science doi: 10.1126/science.1090842 – volume: 11 start-page: 607 issn: 1471-0072 issue: 9 year: 2010 ident: 72_37815447 publication-title: Nature reviews. Molecular cell biology doi: 10.1038/nrm2950 – volume: 45 start-page: 553 issn: 0028-3908 issue: 4 year: 2003 ident: 16_17758438 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(03)00198-9 – volume: 79 start-page: 1086 issn: 0896-6273 year: 2013 ident: 31_47715364 publication-title: Neuron doi: 10.1016/j.neuron.2013.08.032 – volume: 23 start-page: 1054 issn: 0959-4973 issue: 10 year: 2012 ident: 25_43367613 publication-title: Anti-cancer drugs doi: 10.1097/CAD.0b013e32835739dd – volume: 151 start-page: 1417 issn: 0092-8674 year: 2012 ident: 44_45706308 publication-title: Cell doi: 10.1016/j.cell.2012.11.022 – volume: 53 start-page: 649 issn: 0006-3223 issue: 8 year: 2003 ident: 19_17593975 publication-title: Biological psychiatry doi: 10.1016/S0006-3223(03)00231-2 – volume: 7 start-page: 55 issn: 1662-5145 year: 2013 ident: 65_49653098 – volume: 13 start-page: 458 issn: 1562-2975 issue: 6 year: 2012 ident: 73_40493093 publication-title: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry doi: 10.3109/15622975.2011.585663 – volume: 69 start-page: 359 issn: 0896-6273 year: 2011 ident: 70_48325913 publication-title: Neuron doi: 10.1016/j.neuron.2010.12.023 – volume: 14 start-page: 105 issn: 0092-8674 issue: 1 year: 1978 ident: 9_4590366 publication-title: Cell doi: 10.1016/0092-8674(78)90305-7 – volume: 77 start-page: 126 issn: 0026-895X issue: 2 year: 2010 ident: 24_35995229 publication-title: Molecular Pharmacology doi: 10.1124/mol.109.061333 – volume: 8 start-page: R19 issn: 1465-6906 issue: 2 year: 2007 ident: 28_23645204 publication-title: Genome biology doi: 10.1186/gb-2007-8-2-r19 – volume: 28 start-page: 3729 issn: 0270-6474 issue: 14 year: 2008 ident: 51_30723630 publication-title: Journal of Neuroscience doi: 10.1523/JNEUROSCI.5731-07.2008 – volume: 29 start-page: 3603 issn: 0305-1048 issue: 17 year: 2001 ident: 3_11295946 publication-title: Nucleic Acids Research doi: 10.1093/nar/29.17.3603 – volume: 29 start-page: 11451 issn: 0270-6474 issue: 37 year: 2009 ident: 13_35573231 publication-title: Journal of Neuroscience doi: 10.1523/JNEUROSCI.1758-09.2009 – volume: 25 start-page: 1378 issn: 0269-8811 issue: 10 year: 2011 ident: 27_39012577 publication-title: Journal of Psychopharmacology doi: 10.1177/0269881110393049 – volume: 12 start-page: 599 issn: 0890-9369 issue: 5 year: 1998 ident: 64_5925119 publication-title: Genes & Development doi: 10.1101/gad.12.5.599 – volume: 139 start-page: 1017 issn: 0306-4522 issue: 3 year: 2006 ident: 17_22090726 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.12.058 – volume: 324 start-page: 930 issn: 0036-8075 issue: 5929 year: 2009 ident: 66_34597445 publication-title: Science doi: 10.1126/science.1170116 – volume: 32 start-page: 1884 issn: 0270-6474 issue: 5 year: 2012 ident: 54_41601956 publication-title: Journal of Neuroscience doi: 10.1523/JNEUROSCI.3136-11.2012 – volume: 211 start-page: 420 issn: 0014-4827 issue: 2 year: 1994 ident: 5_14703568 publication-title: Experimental cell research doi: 10.1006/excr.1994.1107 – volume: 196 start-page: 200 issn: 0166-4328 issue: 2 year: 2009 ident: 74_32035409 publication-title: Behavioural brain research doi: 10.1016/j.bbr.2008.08.039 – volume: 14 start-page: 268 issn: 1072-0502 issue: 4 year: 2007 ident: 7_28300649 publication-title: Learning & Memory doi: 10.1101/lm.500907 – volume: 7 start-page: e40262 issn: 1932-6203 issue: 6 year: 2012 ident: 39_43033534 doi: 10.1371/journal.pone.0040262 – volume: 17 start-page: 105 year: 2012 ident: 11_49653094 publication-title: EOMD – volume: 10 start-page: 1116 issn: 1097-6256 issue: 9 year: 2007 ident: 56_29320008 publication-title: Nature neuroscience doi: 10.1038/nn1944 – volume: 11 start-page: 1271 issn: 1097-6256 issue: 11 year: 2008 ident: 48_32196907 publication-title: Nature neuroscience doi: 10.1038/nn.2207 – volume: 65 start-page: 143 issn: 0031-6997 issue: 1 year: 2013 ident: 49_44870054 publication-title: Pharmacological Reviews doi: 10.1124/pr.111.005397 – volume: 29 start-page: 739 issn: 0149-7634 issue: 4-5 year: 2005 ident: 50_18888825 publication-title: Neuroscience and biobehavioral reviews doi: 10.1016/j.neubiorev.2005.03.015 – volume: 8 start-page: 2317 issn: 0964-6906 issue: 12 year: 1999 ident: 10_37686686 publication-title: Human Molecular Genetics doi: 10.1093/hmg/8.12.2317 – volume: 1087 start-page: 80 issn: 0006-3002 issue: 1 year: 1990 ident: 12_9170839 publication-title: Biochimica et Biophysica Acta. Protein Structure and Molecular Enzymology doi: 10.1016/0167-4781(90)90124-K – volume: 8 start-page: e58473 issn: 1932-6203 year: 2013 ident: 67_48234658 doi: 10.1371/journal.pone.0058473 – volume: 4 start-page: 155 issn: 1946-6234 year: 2012 ident: 29_47539373 publication-title: Science Translational Medicine – volume: 48 start-page: 303 issn: 0896-6273 issue: 2 year: 2005 ident: 36_19495778 publication-title: Neuron doi: 10.1016/j.neuron.2005.09.023 – volume: 9 start-page: 519 issn: 1097-6256 issue: 4 year: 2006 ident: 68_21847439 publication-title: Nature neuroscience doi: 10.1038/nn1659 – volume: 108 start-page: 18108 issn: 0027-8424 issue: 44 year: 2011 ident: 38_41040395 publication-title: PNAS doi: 10.1073/pnas.1114863108 – volume: 13 start-page: 655 issn: 0022-3042 issue: 8 year: 1966 ident: 21_7173440 publication-title: Journal of neurochemistry doi: 10.1111/j.1471-4159.1966.tb09873.x – volume: 164 start-page: 1711 issn: 0007-1188 issue: 6 year: 2011 ident: 58_39966655 publication-title: British journal of pharmacology doi: 10.1111/j.1476-5381.2011.01489.x – volume: 502 start-page: 472 issn: 0028-0836 year: 2013 ident: 34_47362447 publication-title: Nature doi: 10.1038/nature12750 – volume: 17 start-page: 584 issn: 1359-4184 issue: 6 year: 2012 ident: 6_40716573 publication-title: Molecular psychiatry doi: 10.1038/mp.2011.107 – volume: 145 start-page: 423 issn: 0092-8674 issue: 3 year: 2011 ident: 26_39742981 publication-title: Cell doi: 10.1016/j.cell.2011.03.022 – volume: 3 start-page: 107 issn: 1946-6234 year: 2011 ident: 37_42560642 publication-title: Science Translational Medicine – volume: 73 start-page: 309 issn: 0306-5251 issue: 2 year: 2012 ident: 53_41090780 publication-title: British journal of clinical pharmacology doi: 10.1111/j.1365-2125.2011.04100.x – reference: 15655562 - Mol Psychiatry. 2005 Apr;10(4):345-52 – reference: 8143791 - Exp Cell Res. 1994 Apr;211(2):420-3 – reference: 10545613 - Hum Mol Genet. 1999 Nov;8(12):2317-23 – reference: 23908608 - Front Integr Neurosci. 2013 Jul 29;7:55 – reference: 667927 - Cell. 1978 May;14(1):105-13 – reference: 16242410 - Neuron. 2005 Oct 20;48(2):303-14 – reference: 23652932 - Transl Psychiatry. 2013;3:e255 – reference: 23469282 - PLoS One. 2013;8(3):e58473 – reference: 5950056 - J Neurochem. 1966 Aug;13(8):655-69 – reference: 21868513 - Anticancer Res. 2011 Sep;31(9):2723-32 – reference: 20683471 - Nat Rev Mol Cell Biol. 2010 Sep;11(9):607-20 – reference: 22371047 - Mol Psychiatry. 2013 May;18(5):582-94 – reference: 23382250 - Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9 – reference: 12748177 - J Biol Chem. 2003 Jul 25;278(30):27586-92 – reference: 9499396 - Genes Dev. 1998 Mar 1;12(5):599-606 – reference: 19917878 - Mol Pharmacol. 2010 Feb;77(2):126-35 – reference: 24439381 - Cell. 2014 Jan 16;156(1-2):261-76 – reference: 17149751 - J Neurosci Res. 2007 Feb 15;85(3):525-35 – reference: 19372391 - Science. 2009 May 15;324(5929):930-5 – reference: 11522830 - Nucleic Acids Res. 2001 Sep 1;29(17):3603-10 – reference: 11572963 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11024-31 – reference: 1698097 - Biochim Biophys Acta. 1990 Sep 10;1087(1):80-6 – reference: 19759294 - J Neurosci. 2009 Sep 16;29(37):11451-60 – reference: 22023150 - Br J Clin Pharmacol. 2012 Feb;73(2):309-10 – reference: 22863973 - Anticancer Drugs. 2012 Nov;23(10):1054-66 – reference: 21812623 - World J Biol Psychiatry. 2012 Sep;13(6):458-67 – reference: 18849986 - Nat Neurosci. 2008 Nov;11(11):1271-82 – reference: 2419322 - J Biol Chem. 1986 Feb 25;261(6):2786-90 – reference: 24175168 - World J Psychiatry. 2012 Jun 22;2(3):49-57 – reference: 24153300 - Nature. 2013 Oct 24;502(7472):472-9 – reference: 17453016 - Nat Rev Neurosci. 2007 May;8(5):355-67 – reference: 667928 - Cell. 1978 May;14(1):115-21 – reference: 12706951 - Biol Psychiatry. 2003 Apr 15;53(8):649-59 – reference: 12907316 - Neuropharmacology. 2003 Sep;45(4):553-63 – reference: 2416432 - Cancer Res. 1986 Feb;46(2):713-6 – reference: 1382840 - Cancer Res. 1992 Oct 1;52(19):5213-8 – reference: 596982 - Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36 – reference: 17291332 - Genome Biol. 2007;8(2):R19 – reference: 21267076 - PLoS One. 2011;6(1):e14524 – reference: 23052292 - Sci Transl Med. 2012 Oct 10;4(155):155ps19 – reference: 14593184 - Science. 2003 Oct 31;302(5646):890-3 – reference: 8279933 - Arch Gen Psychiatry. 1994 Jan;51(1):8-19 – reference: 21585346 - Br J Pharmacol. 2011 Nov;164(6):1711-21 – reference: 21682946 - Int J Neuropsychopharmacol. 2012 Jun;15(5):669-79 – reference: 17726478 - Nat Neurosci. 2007 Sep;10(9):1116-24 – reference: 22025706 - Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18108-13 – reference: 16500030 - Neuroscience. 2006;139(3):1017-29 – reference: 24050399 - Neuron. 2013 Sep 18;79(6):1086-93 – reference: 18817816 - Behav Brain Res. 2009 Jan 23;196(2):200-6 – reference: 21242991 - Mol Psychiatry. 2012 Feb;17(2):173-84 – reference: 17522015 - Learn Mem. 2007 Apr;14(4):268-76 – reference: 16945350 - Biol Psychiatry. 2007 Jul 1;62(1):55-64 – reference: 16501568 - Nat Neurosci. 2006 Apr;9(4):519-25 – reference: 17012225 - Carcinogenesis. 2007 Mar;28(3):560-71 – reference: 22784618 - BMC Syst Biol. 2011;5 Suppl 3:S12 – reference: 24452011 - Neuropharmacology. 2014 May;80:115-32 – reference: 23319547 - Pharmacol Rev. 2013 Jan;65(1):143-55 – reference: 22768266 - PLoS One. 2012;7(6):e40262 – reference: 18571370 - J Anxiety Disord. 2009 Jan;23(1):38-45 – reference: 18385331 - J Neurosci. 2008 Apr 2;28(14):3729-37 – reference: 21262856 - J Psychopharmacol. 2011 Oct;25(10):1378-87 – reference: 21496894 - Cell. 2011 Apr 29;145(3):423-34 – reference: 22246241 - Int J Oncol. 2012 May;40(5):1533-42 – reference: 21894152 - Mol Psychiatry. 2012 Jun;17(6):584-96 – reference: 19372393 - Science. 2009 May 15;324(5929):929-30 – reference: 22302827 - J Neurosci. 2012 Feb 1;32(5):1884-97 – reference: 23260135 - Cell. 2012 Dec 21;151(7):1417-30 – reference: 25888486 - Int J Neuropsychopharmacol. 2015 Apr;18(6). pii: pyv026. doi: 10.1093/ijnp/pyv026 – reference: 21262472 - Neuron. 2011 Jan 27;69(2):359-72 – reference: 22321459 - Behav Brain Res. 2012 Apr 21;230(1):85-91 – reference: 15925699 - Neurosci Biobehav Rev. 2005;29(4-5):739-59 – reference: 22339643 - Expert Opin Emerg Drugs. 2012 Mar;17(1):105-26 – reference: 18923034 - J Neurosci. 2008 Oct 15;28(42):10576-86 – reference: 22049069 - Sci Transl Med. 2011 Nov 2;3(107):107ra109 – reference: 22681167 - Curr Pharm Des. 2012;18(36):5879-89 |
SSID | ssj0024536 |
Score | 2.4593005 |
Snippet | Background:Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the... Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant... Background: Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the... |
SourceID | swepub pubmedcentral proquest pubmed crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | pyu032 |
SubjectTerms | Animals Antidepressants Antidepressive Agents - pharmacology Brain-derived neurotrophic factor Brain-Derived Neurotrophic Factor - genetics Brain-Derived Neurotrophic Factor - metabolism Butyric Acid - pharmacology Depressive Disorder - drug therapy Depressive Disorder - genetics Depressive Disorder - metabolism Dioxygenases - metabolism Disease Models, Animal DNA methylation DNA Methylation - drug effects Epigenetics Histone Deacetylase Inhibitors - pharmacology Male Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Rats Up-Regulation - drug effects |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb5RAEN409cUX42_Rqmti7sEUK-wuuzwY05o2F9OaJt4lfSPADim27p0FEvkP_LOdOeBOtLkXQphZcsfM7H4LM98w9jaH0OaQgy9lEeEhVr6RMvUFgM7RaYzNqFD47Gs0ncsvF-pihw3NOPsHWN26taN-UvOb6_e_frafMOA_9mRIB-V3tzxYts0HgXPxHVySNEXomTQb0j0l-jKjwA-k0n2h3j-DR0vTqNztL9T5f_LkiGJ0tSyd3Gf3ejzJDzsHeMB2wD1kk_OOkLrd57NNfVW1zyf8fENV3T5ivw9dXfbJsPiI_dPyCnhHaMwXBf-2sGXzgx81dUuMErys-GBOsJxe4fLUcZxiKLMdxY7PjmcBXrN0rvxpaylLhrpUt13OHT-lJKWKxIg8-ZF1BSfm68dsfnI8-zz1-94Mfq5MUPu47cPohSiNJehCZnlsbBqnlDUFNii0zNIIp9HQKANgFKSIezIit8cpIAtlIZ6wXbdw8IzxyIgoKNAYBQp0EOJIsFJoHUFmilh77N1gliTvicupf8Z10n1AFwnZMOls6KH7DcrLjq_jdrXXaN_tGnuD7ZPBKxNB7PVShEJ57M1ajAFJX1lSB4umSoJIUV4uIvEtOjrCjRyV_XrsaedO69-CGBQxVGA8pkeOtlYgQvCxxJWXK2Jw6iZgYrznpHPJ0ZD-0hWeQaIQ6Ivw-fb_-ILdRXiouhdOe2y3vmngJUKwOnu1Cq8_oMc1HA priority: 102 providerName: Scholars Portal |
Title | Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25618518 https://www.proquest.com/docview/3170143235 https://www.proquest.com/docview/1652400080 https://www.proquest.com/docview/1765975901 https://pubmed.ncbi.nlm.nih.gov/PMC4368891 http://kipublications.ki.se/Default.aspx?queryparsed=id:131079937 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVg98IF8U1gKUZCPaCNSmI7dk5oi7qq0O5SQVfqLUpiRxsWkkKSQ_4BP5uZxGmJQL1YUWZStZ2x8zyeeUPI29T4OjWpcTnPAhhC4SrOY5cZI1NwGqUTLBS-vAqW1_zTRmxswK2yaZXDmtgt1LpMMUY-Y0gczpnPxIftTxe7RuHpqm2hcZccI3UZpnTJzX7DxQWz1UWe63EhbX0ebOJn-bdiO9u2zXvmj95Ioyq3v8DmvzmTI2bR7m10_oDctzCSnvV2f0jumOIRma56Hur2lK73ZVXVKZ3S1Z6hun1Mfp8VdW5zYOGfdS_yW0N7HmNaZvRrqfPmB503dYtEEjSv6GBFoylGbmlcUFhZMKEdxAVdL9Ye3NN4LdxlqzE5BptTt32qHb3A3KQKxQA46VwXGUXC6yfk-nyx_rh0bUsGNxXKq13Y7cGkNUEcciMznqSh0nEYY7KU0V4meRIHsHr6SihjlDAxwJ0EOe1h5ic-z9hTclSUhXlOaKBY4GVgjAwE0vPhSaM5kzIwicpC6ZB3g1mi1PKVY9uM71F_bs4itGHU29ABrxuUtz1Nx__VXoN9D2ucDLaP7Gyuor3vOeTNTgzzEA9X4sKUTRV5gcB0XADgB3RkAPs3rPZ1yLPenXbfBaAnQCdPOUSOHG2ngDzgY0mR33R84NhEQIXwmdPeJUeP2Fu3cGUiAfie-S8O_8aX5B6gQtHHmU7IUf2rMa8AedXJpJteE3I8X1ytvky6-AWMl1zBuP68-QM9rDZr |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdG9wAviP8EBjMS9AEt6hLbifOA0AqdOtZVFWTS3rIkdkQYpIWkQvkGfBo-I3d10hKB-raXKspdolT3s31n3_2OkJepdlWqU21znnnwEwhbch7bTGs_BdBIlWCh8NnUG5_zDxfiYof8bmthMK2ynRNXE7Wap7hHPmBIHM6Zy8TbxXcbu0bh6WrbQsPA4lTXPyFkK9-cvAf7vnLd41H4bmw3XQXsVEinsiFgAdxpLw649jOepIFUcRBjvo9WTubzJPZgAnClkFpLoWNYsROkZQfwJi7PGLz3BtnlDEKZHtkdjqazjxt2P8GaeibHdrjwm4rAw4AN8i_FYrCol4fM7ayBnbq6v9zbf7M0O1ymq_Xv-A653Tiu9Mgg7S7Z0cU90p8Z5uv6gIabQq7ygPbpbMOJXd8nv46KKm-ybsGW9iS_0tQwJ9N5Rj_NVb78RofLqkbqCpqXtMWNVhT3imlcUJjLMIUexAUNR6ED9xReC3tcK0zHwXbYtUnuoxPMhipRDC4uHaoio0ix_YCcX4u5HpJeMS_0Y0I9yTwnA2NkIPAdF57UijPf93Qis8C3yOvWLFHaMKRjo46vkTmpZxHaMDI2tADnrfLCEIP8X20f7LtdY6-1fdTMH2W0QbtFXqzFMPLxOCcu9HxZRo4nMAEYXP4tOr4HESPWF1vkkYHT-lvA2QVnzZEW8TtAWysg83hXUuSfVwzk2LZABvDOvoFk55Hm1hVc6UhARMHcJ9v_4z65OQ7PJtHkZHr6lNwCn1SYXa490qt-LPUz8Puq5Hkz2Ci5vO7x_Qcs3m7t |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antidepressant-Like+Effect+of+Sodium+Butyrate+is+Associated+with+an+Increase+in+TET1+and+in+5-Hydroxymethylation+Levels+in+the+Bdnf+Gene&rft.jtitle=The+international+journal+of+neuropsychopharmacology&rft.au=Ya+Bin+Wei&rft.au=Melas%2C+Philippe+A&rft.au=Wegener%2C+Gregers&rft.au=Math%C3%A9%2C+Aleksander+A&rft.date=2015-01-01&rft.pub=Oxford+University+Press&rft.issn=1461-1457&rft.eissn=1469-5111&rft.volume=18&rft.issue=2&rft_id=info:doi/10.1093%2Fijnp%2Fpyu032 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1461-1457&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1461-1457&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1461-1457&client=summon |